These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Efficacy of carbapenems and alternative antimicrobials for treating complicated urinary tract infections caused by third-generation cephalosporin-resistant gram-negative bacteria: A systematic review and meta-analysis of randomised controlled trials. Maeda M; Sunaga T; Sato MT; Hasegawa T; Noma H; Ota E J Infect Chemother; 2024 Nov; 30(11):1147-1155. PubMed ID: 38705237 [TBL] [Abstract][Full Text] [Related]
44. Bacterial distribution and drug resistance in blood samples of children in Jiangxi Region, 2017-2021. Zhou Y; Zhou S; Peng J; Min L; Chen Q; Ke J Front Cell Infect Microbiol; 2023; 13():1163312. PubMed ID: 37424793 [TBL] [Abstract][Full Text] [Related]
45. Ten-year resistance trends in pathogens causing healthcare-associated infections; reflection of infection control interventions at a multi-hospital healthcare system in Saudi Arabia, 2007-2016. Balkhy HH; El-Saed A; Alshamrani MM; Alsaedi A; Al Nasser W; El Gammal A; Aljohany SM; Almunif S; Arabi Y; Alqahtani S; Bonnie HB; Alghoribi M; Alothman A; Almohrij SA Antimicrob Resist Infect Control; 2020 Jan; 9(1):21. PubMed ID: 32000850 [TBL] [Abstract][Full Text] [Related]
46. [Impact of antimicrobial stewardship program on antimicrobial usage and detection rate of multidrug-resistant gram-negative bacteria]. Xu YL; Hu LM; Xie ZZ; Dong YW; Dong L Zhonghua Er Ke Za Zhi; 2019 Jul; 57(7):553-558. PubMed ID: 31269557 [No Abstract] [Full Text] [Related]
47. Prevalence of antibiotic-resistant organisms among hospitalized patients at a tertiary care center in Lebanon, 2010-2018. Moussally M; Zahreddine N; Kazma J; Ahmadieh R; Kan SS; Kanafan ZA J Infect Public Health; 2021 Jan; 14(1):12-16. PubMed ID: 33341479 [TBL] [Abstract][Full Text] [Related]
48. Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018. Barnsteiner S; Baty F; Albrich WC; Babouee Flury B; Gasser M; Plüss-Suard C; Schlegel M; Kronenberg A; Kohler P; Euro Surveill; 2021 Nov; 26(46):. PubMed ID: 34794535 [TBL] [Abstract][Full Text] [Related]
50. Implementation of contact precautions for multidrug-resistant organisms in the post-COVID-19 pandemic era: An updated national Emerging Infections Network (EIN) survey. Howard-Anderson JR; Gottlieb LB; Beekmann SE; Polgreen PM; Jacob JT; Uslan DZ Infect Control Hosp Epidemiol; 2024 Jun; 45(6):703-708. PubMed ID: 38351872 [TBL] [Abstract][Full Text] [Related]
51. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients]. Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922 [No Abstract] [Full Text] [Related]
52. Collateral impacts of pandemic COVID-19 drive the nosocomial spread of antibiotic resistance: A modelling study. Smith DRM; Shirreff G; Temime L; Opatowski L PLoS Med; 2023 Jun; 20(6):e1004240. PubMed ID: 37276186 [TBL] [Abstract][Full Text] [Related]
53. Guo Y; Han R; Jiang B; Ding L; Yang F; Zheng B; Yang Y; Wu S; Yin D; Zhu D; Hu F; Microbiol Spectr; 2022 Aug; 10(4):e0185422. PubMed ID: 35862963 [TBL] [Abstract][Full Text] [Related]
54. Effects of various antimicrobial stewardship programs on antimicrobial usage and resistance among common gram-negative bacilli causing health care-associated infections: A multicenter comparison. Lai CC; Shi ZY; Chen YH; Wang FD J Microbiol Immunol Infect; 2016 Feb; 49(1):74-82. PubMed ID: 26586483 [TBL] [Abstract][Full Text] [Related]
55. Clinical and Genomic Epidemiology of Babiker A; Bower C; Lutgring JD; Petit RA; Howard-Anderson J; Ansari U; McAllister G; Adamczyk M; Breaker E; Satola SW; Jacob JT; Woodworth MH Microbiol Spectr; 2022 Aug; 10(4):e0252221. PubMed ID: 35856667 [TBL] [Abstract][Full Text] [Related]
56. Multidrug-resistant organisms may be associated with bed allocation and utilization efficiency in healthcare institutions, based on national monitoring data from China (2014-2020). Wang XT; Meng H; Pan DF; Zheng XY; Lu WW; Chen C; Su M; Su XY; Liu Z; Ma XJ; Liang PF Sci Rep; 2023 Dec; 13(1):22055. PubMed ID: 38087043 [TBL] [Abstract][Full Text] [Related]
57. The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis. European Antimicrobial Resistance Collaborators Lancet Public Health; 2022 Nov; 7(11):e897-e913. PubMed ID: 36244350 [TBL] [Abstract][Full Text] [Related]
58. Global prevalence of cefiderocol non-susceptibility in Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii, and Stenotrophomonas maltophilia: a systematic review and meta-analysis. Karakonstantis S; Rousaki M; Vassilopoulou L; Kritsotakis EI Clin Microbiol Infect; 2024 Feb; 30(2):178-188. PubMed ID: 37666449 [TBL] [Abstract][Full Text] [Related]
59. Increased antimicrobial resistance during the COVID-19 pandemic. Lai CC; Chen SY; Ko WC; Hsueh PR Int J Antimicrob Agents; 2021 Apr; 57(4):106324. PubMed ID: 33746045 [TBL] [Abstract][Full Text] [Related]
60. A carbapenem-focused antimicrobial stewardship programme implemented during the COVID-19 pandemic in a setting of high endemicity for multidrug-resistant Gram-negative bacteria. Spernovasilis N; Kritsotakis EI; Mathioudaki A; Vouidaski A; Spanias C; Petrodaskalaki M; Ioannou P; Chamilos G; Kofteridis DP J Antimicrob Chemother; 2023 Apr; 78(4):1000-1008. PubMed ID: 36790896 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]